SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ekn who wrote (67265)2/20/2001 12:54:44 AM
From: StockDung  Read Replies (1) of 122087
 
since it appears they only have one client and a search on their phone number shows three press releases all for the same company I would say they are very paticular. Looks like they are trying to

....................SAVE THE WORLD

"A spokesperson for Strategic Communications said: "We are very particular in the companies that we choose to represent. Because we expose a company's story through traditional methods, without hype, it is important that the story has real value. We believe that Ives Health Company and their products have tremendous upside potential and will work hard to present the company to every possible media outlet, broker, analyst, and money manager."

Monday February 19, 9:52 pm Eastern Time
Press Release
Ives Health to Post Summary of the Landmark Java Project That Proves ``T-Factor'' Increases T-Cell (CD-4) Cell Count in HIV/AIDS Patients

CLAREMORE, Okla.--(BW HealthWire)--Feb. 19, 2001--Ives Health Company (OTCBB:IVEH - news):
Public Unveiling of the Java Project Study

Ives Health Company (OTCBB:IVEH - news) announced today that in order to facilitate the public's unbelievable response to T-Factor® and the Java Project, the Company is making a brief summary of the Project, that will include patient profiles, available at iveshealth.com.

The results of this groundbreaking study are now gaining worldwide attention from both the investment and healthcare communities.

Keith Ives, President and Founder of Ives Health Company, stated: ``The sheer amount of excitement surrounding this product has been daunting. When we found the product three years ago, T-Factor® was an unsightly paste that had to be administered through a stomach tube. Thanks to years of dedicated research, we have solved the problems of putting the formula in a pill that is easily swallowed, and preserving that formula until it reaches the consumer. This has required both hard work and vision on the part of our team, our investors, and our clients. We could not be more enthusiastic about helping to improve the lives of hundreds of millions of people who are infected with HIV.''

T-Factor® was released to the public on February 13, 2001, on Ives Health Company's website at iveshealth.com. Mr. Ives continued: ``Because the product has almost no side effects, we are trying to get the word out through HIV and AIDS support groups around the country. We are also attempting to have the product tested and notarized by a celebrity who is battling HIV. HIV is a terrible virus and the enthusiasm that the investment community is showing over T-Factor will help us get the word out to millions of people who desperately need our help.''

About the Java Project and T-Factor®

The Java Project was a landmark AIDS study carried out by Dr. Slayton-Bedeen, an Immunologist and T-Factor® Founder, along with the World Health Organization in Jakarta and Bangkok. The project found that new hormonal inhibitors of the Human Immunodeficiency Virus (HIV), like T-Factor®, might initiate profound and sustained suppression of HIV replication. The T-Factor® formula was administered to 186 HIV-Positive patients of Asian descent with elevated HIV RNA and decreased CD-4 counts, over a period of 24 weeks. The results were dramatic, with over 80% of patients experiencing documented decreases in HIV RNA and enhanced CD-4 counts after 24 weeks.

The T-Factor® formula, acquired by Ives Health Company in 1998, is all-natural, has virtually no side effects, and is readily available over the Internet at iveshealth.com. T-Factor® costs less than $3.00 per day versus $80.00 per day for current HIV drug therapies. New studies are on-going in the United States and recently began in Europe. Findings will be released as the data is reported and validated. T-Factor® is not a cure for HIV, but is intended to extend the lives of those inflicted with the virus.

About Ives Health Company

Ives Health Company is committed to improving consumers ``Total Health'' through their high-quality natural remedies and homeopathic medicines. Ives product formulations use 98.3% pure natural ingredients and deliver an astounding 90% of the active ingredients into the bloodstream. The Company's products compete in the $99.2 billion diet and nutritional product arena under the following branded names: Pharmacy Health and Diet Program®, T-Factor® Immune Enhancement System, Vegi Bears(TM) (a nutritional snack) and other natural remedies for Aches & Pains, Acne (a non-topical oral treatment), Allergy, Antacid, Arthritis, Cough & Sore Throat, Energy, Headache, Sinus, PMS relief, Prostate relief, and Cholesterol control, among others. Please visit iveshealth.com to purchase or to learn more about the Ives family of homeopathic medicines, weight management and natural remedy products.

This news release includes ``forward-looking statements'' that include risk and uncertainties. The forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including without limitation the Company's ability to produce and market products and/or services and other risks detailed from time to time in their Company's reports filed with the Securities Exchange Commission. Please consult with your physician prior to starting a weight loss program.

--------------------------------------------------------------------------------
Contact:

For Ives Health:
Strategic Communications
Investor Relations, 775/828-6576
or
www.iveshealth.com

Ives Health Company Retains Strategic Communications for Investor Relations; Company Will Focus on Shareholder Value


CLAREMORE, Okla.--(BW HealthWire)--Jan. 25, 2001--Ives Health Company (OTCBB:IVEH) announced today that it has retained the services of Strategic Communications, a leading investor and media relations firm.

Keith Ives, Founder of Ives Health Company said: "After thoroughly investigating many investor and public relations options, we have decided that Strategic Communications has the best track record for effectively communicating with the public. Our products offer the best Naturalpath Health Solutions on the market and we will do the public and the media a service by telling them."

A spokesperson for Strategic Communications said

: "We are very particular in the companies that we choose to represent. Because we expose a company's story through traditional methods, without hype, it is important that the story has real value. We believe that Ives Health Company and their products have tremendous upside potential and will work hard to present the company to every possible media outlet, broker, analyst, and money manager."

About Ives Health Company

Ives Health Company is committed to improving consumers' "Total Health" through their high-quality natural remedies and homeopathic medicines. Ives product formulations use 98.3% pure natural ingredients and deliver an astounding 90% of the active ingredients into the bloodstream. The Company's products compete in the $99.2 billion diet and nutritional product arena under the following branded names: Pharmacy Health and Diet Program(TM), T-Factor(TM) Immune Enhancement System, Vegi Bears(TM) (a nutritional snack) and other natural remedies for Aches & Pains, Acne (a non-topical oral treatment), Allergy, Antacid, Arthritis, Cough & Sore Throat, Energy, Headache, Sinus, PMS relief, Prostate relief, Cholesterol control among others. Please visit iveshealth.com to purchase or to learn more about the Ives family of homeopathic medicines, weight management and natural remedy products.

This news release includes "forward-looking statements" that include risk and uncertainties. The forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including without limitation the Company's ability to produce and market products and/or services and other risks detailed from time to time in their Company's reports filed with the Securities Exchange Commission. Please consult with your physician prior to starting a weight loss program.

CONTACT:

For Ives Health Company:

Strategic Communications

Wayne Schumacher, 775/828-6576

KEYWORD: OKLAHOMA

BW0379 JAN 25,2001

9:44 PACIFIC

12:44 EASTERN
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext